Health plans’ reliance on the FDA’s informational chart on birth control options has made it more difficult for patients to access novel contraceptives at no cost. — Former FDA chief of ...

The immediate aftermath of the 2024 presidential election has brought renewed attention to regulatory policy at the U.S. Food and Drug Administration (FDA ... could better chart the progress ...

“This is a significant step forward,” said Peter Lurie, president and executive director of the Center for Science in the Public Interest and a former FDA associate commissioner. These tests ...